Welcome  Guest  ! Sign Up Language
 
 
Home    Markets    Equity    Corporate Info    Smart Quotes
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037 Industry : Pharmaceuticals & Drugs House : Aurobindo  
Market Open - NSE
Rs. 622.25  
-1.05    -0.17%
Vol(000's) 1796.832
on 18-Jun-2019 12:00
 Day low
Day high 
 620.6
627.9 
 52 week low
52 week high 
 565.05
838 
BSE
Rs.622.15
-0.9    -0.14%
Market Open - BSE
Rs. 622.15  
-0.9    -0.14%
Vol(000's) 49.655
on 18-Jun-2019 12:00
 Day low
Day high 
 620.55
627.9 
 52 week low
52 week high 
 566
838 
NSE
Rs.622.25
-1.05    -0.17%
BSE NSE  
Technical Chart
1D   | 1M   | 3M   | 1Y  | 3Y  | 5Y
You need to upgrade your Flash Player
 
 Stock Summary
Prev.Close(Rs.)  623.05
Today's Open(Rs.)  625.00
Trade Value  30975592
Volume  49655
Divident Yield(%)  0.40
TTM EPS (Rs.)  26.11
P/E Ratio  23.83
Book Value(Rs.)  193.72
Face Value(Rs.)  1
MCap(Rs.in Mn)  364527.40
 
 Ratio
Price/Earnings(TTM)  23.83
Price/Sales(TTM)  3.05
Price/Book(MRQ)  3.21
PAT Margin  17.59
ROCE  19.02
 Company News    Previous News
Aurobindo Pharma to invest $200 million on Capex in FY20
06/17/2019 00:00 Hrs IST

Aurobindo Pharma is eyeing to invest up to $200 million on Capex and over five percent of sale value on Research and Development (R&D) during the current financial year. The majority of the CAPEX should be in terms of creating certain both finished dosage and API capacities...

 
Aurobindo Pharma surges on aiming to inv...
Aurobindo Pharma informs about analyst m...
More>
 Financials
  QUARTERLY Mar 19 ANNUAL 19
Net Profit (Rs.Mn) 4601.4 15297.3
Gross Profit (Rs.Mn) 6184.8 19646.2
Operating Profit (Rs.Mn) 7626.5 25085.7
Net Sales (Rs.Mn) 32805.8 122578.9
 
 PAT Growth
Chart.
 
 Rolling Forward P/E (EOD)
12 Months Rolling Forward P/E (X)
 Competitors (Rs. in Crore) 
Sumpoorna's Analysis
NameChartYear EndPE(X)ROE(%)Earnings Growth1-Year ReturnOperating EfficiencyAsset Use EfficiencyEquity Leverage
       PAT MarginROCEAsset Turnover RatioDebt/Equity
Aurobindo Pharma 20180323.8319.686.211.2717.5919.020.710.37
Industry Average - - 31.54 18.02-62.97-3.2919.3922.500.610.22
Cipla 20180323.3610.9650.51-9.6712.8314.030.700.01
Lupin 20180320.848.91-57.24-21.4513.3311.720.550.00
Cadila Healthcare 20180314.9415.1964.80-41.6218.7315.470.460.37
Glenmark Pharma 2018039.9910.24-52.61-9.4715.7711.020.400.29
 
 Event Calendar
Bonus Issue | Book Closure |
Board Meeting
 
Record DateBonus Ratio
20/Jul/151 : 1
07/Mar/001 : 1
26/Oct/981 : 1

Sumpoorna About Us
Customer Service
Our Offering
Open an account
Channel Partners
Contact Us
Career

Markets News
Equity
Derivatives
Commodities
Currency
IPOs
Mutual Fund

Quick Links EasyPolicy.com NSE
BSE
SEBI
MCX
FMC
RBI

Navigate Login - BackOffice
Login - Now Online
Fund Transfer
Download
Sitemap
Legal

ToolsPortfolio Tracker
Stock Watch
Advanced Charting



Refer A Friend
Facebook
Twiter
Blog
Linkedin
ATTENTION INVESTORS : "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors"
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
SEBI REGI NO : NSE CASH : INB231429037 | NSE F&O : INF231429037 | NSE CURR : INE231429037 | BSE CASH : INB011429033 | BSE F&O : INF011429033 | MCX : INZ000037836 |MEMBER CODE : NSE : 14290 | BSE : 6404 | MCX CODE: 46150| DP Sebi Regn. No: IN-DP-CDSL-665-2012
The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us.
Copyright © 2014 SUMPOORNA Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.